Work

MEK Inhibition by Selumetinib Enhances the Antitumor and Anti-Metastatic Effects of Chemoradiation Therapy in Orthotopic Human Lung Cancer Models

Year: 2014

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2014.05.2300

Authors: S. Furutani, R. Komaki, P.D. Smith, J.M. Jürgensmeier, O. Takahashi, T. Rabin, R.S. Herbst, M.S. O'Reilly

Institutions: The University of Texas MD Anderson Cancer Center, AstraZeneca (United Kingdom), Yale Cancer Center, Yale University

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2044978871

FWCI:

Cites:

Cited by:

Related to: 10